Naproxen Should NOT Be Used After Open Heart Surgery
Naproxen is contraindicated for perioperative pain management in the setting of cardiac surgery, specifically including coronary artery bypass graft (CABG) procedures. 1
FDA Black Box Warning
The FDA label for naproxen explicitly states that it is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery 1. This is a black box warning—the strongest safety warning issued by the FDA—and takes precedence over other considerations.
Guideline-Based Recommendations
Current evidence-based guidelines for pain management after cardiac surgery specifically recommend avoiding NSAIDs in this population 2:
- NSAIDs are associated with renal dysfunction after cardiac surgery 2
- Selective COX-2 inhibitors carry significant risk of thromboembolic events after cardiac surgery 2
- The 2019 ERAS (Enhanced Recovery After Surgery) cardiac surgery guidelines explicitly state that "the safest nonopioid analgesic may be acetaminophen" 2
Recommended Multimodal Approach Instead
The guidelines strongly recommend a multimodal opioid-sparing strategy that excludes NSAIDs but includes 2:
- Acetaminophen (1 g every 8 hours, preferably IV initially)
- Tramadol (produces 25% decrease in morphine consumption)
- Pregabalin or Gabapentin (600 mg gabapentin 2 hours before surgery, or pregabalin 1 hour before and for 2 days post-op)
- Dexmedetomidine (reduces opioid requirements and may reduce acute kidney injury)
- Regional anesthesia techniques (fascial plane blocks such as erector spinae plane or parasternal intercostal plane blocks) 3, 4
Why the Contraindication Exists
The cardiovascular and renal risks are particularly concerning in cardiac surgery patients:
- Increased risk of serious cardiovascular thrombotic events, MI, and stroke 1
- Renal dysfunction risk is elevated in a population already at high risk for acute kidney injury 2
- Potential impact on graft patency in CABG patients 5
- Bleeding concerns in anticoagulated patients 5
Recent Research Context
While a 2026 meta-analysis 5 showed that NSAIDs when used demonstrated lower pain scores and reduced opioid consumption at 24-48 hours without significant differences in complications, the authors themselves acknowledged small sample sizes and called for larger trials. A 2025 cohort study 6 found 12% AKI rate after NSAID use post-cardiac surgery, with baseline renal function being the strongest predictor. These studies do not override the FDA contraindication or guideline recommendations.
Clinical Bottom Line
Do not use naproxen after open heart surgery. Use acetaminophen as the foundation of your multimodal analgesic regimen, combined with tramadol, gabapentinoids, dexmedetomidine, and regional anesthesia techniques as appropriate. This approach provides effective pain control while avoiding the cardiovascular, thrombotic, and renal risks that make NSAIDs contraindicated in this specific population.